Maplelane Capital’s AB InBev BUD Stock Holding History

Maplelane Capital’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-154,000	Closed	-$12.9M	–	122
2019 Q1	$12.9M	Sell	154,000 -146,000	-49%	-$11.2M	0.36%	68
2018 Q4	$19.7M	Buy	+300,000	New	+$23M	0.57%	44

Other funds holding BUD

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Maplelane Capital's BUD Position: Q2 2019 in Review

Maplelane Capital sold out of AB InBev (BUD) in Q2 2019, closing a stake of 1 share.

Maplelane Capital first reported a position in BUD in Q2 2013 and held it in 3 quarters. The position peaked at $3.29M in Q4 2018. 507 funds tracked by Wall St. Rank hold BUD as of Q2 2019.

Maplelane Capital reported no remaining AB InBev position as of Q2 2019 after selling out during the quarter.
Maplelane Capital sold 1 AB InBev share in Q2 2019.
Maplelane Capital first reported a position in AB InBev in Q2 2013 and held it in 3 quarters.
Maplelane Capital's AB InBev position peaked at $3.29M in Q4 2018.
507 funds tracked by Wall St. Rank held AB InBev as of Q2 2019.

Based on Maplelane Capital's 13F filing for Q2 2019, filed 14 Aug 2019.